Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iraq Healthcare Wire.
Press releases published on August 25, 2025
Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals
GlobeNewswire
·
August 25, 2025
“We had a great first 6 months, with 33% year-over-year growth. We have also exceeded our internal metrics across all verticals in the first seven months of the year, reinforcing the strength of our strategy. A key focus has been our investment in making …
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team …
Option Care Health To Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
BANNOCKBURN, Ill., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor …
OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors
GlobeNewswire
·
August 25, 2025
WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to …
Kyverna Therapeutics to Present at Upcoming Investor Conferences in September
GlobeNewswire
·
August 25, 2025
EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, …
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
GlobeNewswire
·
August 25, 2025
MP0533 data presented at European Hematology Association (EHA) highlights improved response rates and antitumor activity in low disease burden patients; additional data under amended dosing scheme expected in Q4 2025 IND filing on first radio-DARPin …
Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions
GlobeNewswire
·
August 25, 2025
WARREN, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment …
Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight
GlobeNewswire
·
August 25, 2025
New York, USA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight Insmed’s BRINSUPRI (brensocatib) has reached a significant regulatory milestone, earning FDA …
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
GlobeNewswire
·
August 25, 2025
WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in …
Dr. Kevin Ciresi Scholarship for Medical Students Opens Applications for Aspiring Future Physicians
GlobeNewswire
·
August 25, 2025
DANVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Dr. Kevin Ciresi Scholarship for Medical Students officially announces the opening of its 2026 application cycle, offering undergraduate students across the United States an opportunity to pursue …
Protecting healthcare workers protects us all:
GlobeNewswire
·
August 25, 2025
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Canadian healthcare workers deserve the same on-the-job protections as workers in every other sector — and new national standards may finally deliver them. More than 1,700 physicians, nurses, scientists, engineers …
Protéger le personnel de la santé, c’est nous protéger tous
GlobeNewswire
·
August 25, 2025
TORONTO, 25 août 2025 (GLOBE NEWSWIRE) -- Le personnel de la santé au Canada mérite les mêmes protections au travail que les employés de tous les autres secteurs, et de nouvelles normes nationales pourraient enfin les leur garantir. Plus de 1 700 médecins, …
NLP in Healthcare & Life Sciences Market Surges to $16.01 billion by 2030 - Dominated by Microsoft (US), Google (US), IQVIA (US)
GlobeNewswire
·
August 25, 2025
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the NLP in Healthcare …
Baylor Genetics to Showcase RNA Sequencing Breakthroughs for Rare Disease Diagnosis at 2025 AGBT Precision Health Meeting
GlobeNewswire
·
August 25, 2025
HOUSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its participation in the 2025 Advances in Genome Biology and Technology (AGBT) Precision Health Conference, …
Husband Material Ministries Announces New Book by Drew Boa: "Outgrow Porn: Find Lasting Freedom Without Fighting an Exhausting Battle—A Man's Guide to Healing"
GlobeNewswire
·
August 25, 2025
Colorado Springs, CO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Husband Material Ministries, a leading nonprofit organization dedicated to helping men find lasting freedom from pornography, is proud to announce the release of a groundbreaking new book by its …
Immix Biopharma to Present at the Stifel 2025 Healthcare Conference
GlobeNewswire
·
August 25, 2025
Los Angeles, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced …
IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics
GlobeNewswire
·
August 25, 2025
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Empowered Patient Podcast with Karen Jagoda recently featured Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. (iMDx) (Nasdaq: IMDX), in an episode on “Democratizing Molecular …
The Sequoia Project Announces Detailed Agenda of Virtual Data Usability Workshop, Co-Sponsored by AHIMA
GlobeNewswire
·
August 25, 2025
VIENNA, Va., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Sequoia Project, a non-profit and trusted advocate for nationwide health IT interoperability, in partnership with the American Health Information Management Association (AHIMA), is releasing the full …
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9
GlobeNewswire
·
August 25, 2025
HOUSTON, TX, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on September 9, 2025, at 4:15 p.m. ET. Attendees will gain an inside look at Nexalin’s …
Global Suppositories Market to Surpass USD 2.05 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 25, 2025
Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global suppositories market, valued at US$1.56 billion in 2024, stood at US$1.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.7% from 2025 to 2030, culminating in a forecasted …